Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keerthi Reddy is active.

Publication


Featured researches published by Keerthi Reddy.


Pediatric Allergy and Immunology | 2018

Youtube and Food Allergy: An Appraisal of the Educational Quality of Information

Keerthi Reddy; Mary Kearns; Santiago Alvarez‐Arango; Ismael Carrillo-Martin; Nathaly Cuervo-Pardo; Lyda Cuervo-Pardo; Ves Dimov; David M. Lang; Sonia Lopez-Alvarez; Brian C. Schroer; Kaushik Mohan; Mark Dula; Shimin Zheng; Claudia A. Kozinetz; Alexei Gonzalez-Estrada

Food allergy affects an estimated 8% of children and 3% of adults in the United States. Food‐allergic individuals increasingly use the web for medical information. We sought to determine the educational quality of food allergy YouTube videos.


Expert Opinion on Pharmacotherapy | 2017

Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis

Alexei Gonzalez-Estrada; Keerthi Reddy; Ves Dimov; Frank Eidelman

ABSTRACT Introduction: Olopatadine hydrochloride is an antihistamine and mast cell stabilizer available as oral, intranasal and ocular preparations. Most of the practical applications of olopatadine therapy focus on the treatment of allergic rhinoconjunctivitis via intranasal and ocular routes. Areas covered: This article was created from a comprehensive literature search with information taken from meta-analyses, systematic reviews, and clinical trials of children and adults. The articles that have been selected, evaluate the use of intranasal and ocular antihistamines and their role in allergic rhinoconjunctivitis. Expert opinion: Olopatadine is significantly more effective than placebos in relieving the symptoms of allergic rhinoconjunctivitis. It can function both as a viable alternative or addition to first line therapies such as intranasal steroids and oral antihistamines.


The Journal of Allergy and Clinical Immunology: In Practice | 2018

Bullous Fixed Drug Eruption Secondary to Chlorthalidone

Nathaly Cuervo-Pardo; Aurora González-Estrada; Lyda Cuervo-Pardo; Keerthi Reddy; Alexei Gonzalez-Estrada

A fixed drug eruption (FDE) is a delayed hypersensitivity reaction characterized by solitary or multiple hyperpigmented oval lesions that may affect any part of the body. These lesions have a predilection for the trunk, lips, hands, and genital mucosa, and may recur on the same sites upon introduction of the causative agent. The drugs most commonly associated with FDE are antibiotics, analgesics, and anticonvulsants. We present a case of chlorthalidone-induced bullous FDE. A 60-year-old woman with a medical history of hypertension and seasonal allergic rhinitis presented with a 4-year history of a recurring annual rash. Her only medication was chlorthalidone, which the patient had been taking consistently for the past 15 years. On presentation, she exhibited violaceous, pruritic, painful, 4-cm, circular papules with central blistering (Figure 1, A) located in her eyelids (Figure 1, B), lips (Figure 1, C), trunk, and extremities. The lesions recurred on the same location each year and lasted for approximately 1 week with complete resolution in 1 month (Figure 1, D). Laboratory workup was within normal limits including complete blood cell count with differential, complete metabolic panel, erythrocyte sedimentation rate, C-reactive protein, C3, C4, antinuclear antibody, and urinalysis. Initial biopsy with hematoxylin and eosin stain and immunofluorescence was nonconclusive. She was initially treated with desloratadine 5 mg, hydroxyzine 25 mg, and betamethasone cream daily without improvement. A repeat biopsy from a latephase lesion revealed nonspecific postinflammatory hyperpigmentation. The main differential diagnosis included necrotizing angiitis, erythema multiforme, and Steven-Johnson syndrome. Chlorthalidone was held because of a suspected FDE. Following this intervention, the patient remained lesion free for the last 18 months with the exception of hyperpigmented cutaneous changes on previously affected areas (Figure 1, E). Patch testing and challenge were declined. The patient was instructed to avoid all thiazide-type diuretics and use equally efficacious alternatives.


Case Reports | 2017

Poland syndrome: a case report

Apurva Bansal; Keerthi Reddy; Kristen Dinsmore; Alexei Gonzalez-Estrada

Poland syndrome (PS) is a rare chest wall developmental anomaly characterised by ipsilateral agenesis/hypoplasia of the sternocostal head of pectoralis major, hypoplasia of nipple or breast, absence of subcutaneous fat, multiple rib abnormalities, elevated and rotated scapula (Sprengel deformity) and ipsilateral digit abnormalities (brachydactyly, syndactyly). These findings vary and all are rarely found in a single individual. Our case involves an 8-year-old boy with no medical history who presented for evaluation of chronic rhinitis. There was no breathing or cardiac complaints on review of systems. Physical examination showed chest asymmetry with right anterior chest wall depression and flattening of the right pectoral region with displaced nipple (figure 1). Abduction of the shoulders showed absence of the sternocostal head of pectoralis major. Hand examination did not show any signs of …


The Journal of Allergy and Clinical Immunology | 2018

Youtube and Eosinophilic Esophagitis: an Assessment of the Educational Quality of Information

Keerthi Reddy; S. Alvarez-Arango; Apurva Bansal; S. Reddy; Lyda Cuervo-Pardo; Mark Dula; Shimin Zheng; Claudia A. Kozinetz; Aurora González-Estrada; Anjali Malkani


Annals of Allergy Asthma & Immunology | 2018

Penicillin skin testing without minor determinate mixture and amoxicillin challenge in the Appalachian region

Nicolas Mungo; Keerthi Reddy; Jan Gutierrez-Sereno; Sonia Lopez-Alvarez; Alexei Gonzalez-Estrada


The Journal of Allergy and Clinical Immunology | 2017

Beta-lactam Skin Testing Without Minor Determinant Mixture and a Two Step Oral Amoxicillin Provocation Test in Patients with a History of Beta-lactam Allergy: A Pilot Study

Keerthi Reddy; Jan J. Gutierrez-Serano; Sonia Alvarez-Lopez; Alexei Gonzalez-Estrada


Gastroenterology | 2017

Youtube as a Source of Information for Inflammatory Bowel Syndrome: A Critical Appraisal

Rufaat Mando; Harika Balagoni; Keerthi Reddy; Apurva Bansal; Adegbemisola Aregbe; Nathaly Cuervo-Pardo; Kailash Bajaj; Shimin Zheng; Mark Dula; Claudia A. Kozinetz; Mark Young; Reddy Chakradhar; Alexei Gonzalez-Estrada


Annals of Allergy Asthma & Immunology | 2017

P483 A Severe delayed rash in a pediatric patient: the dermatitis is in the detail

K. Dinsmore; M. Kearns; Keerthi Reddy; D. Armentrout; Alexei Gonzalez-Estrada


Annals of Allergy Asthma & Immunology | 2017

P031 A case of cefepime IgE-mediated reaction with negative skin testing. should current concentrations be reconsidered?

I. Carrillo-Martin; K. Molony; Keerthi Reddy; D. Youssef; Alexei Gonzalez-Estrada

Collaboration


Dive into the Keerthi Reddy's collaboration.

Top Co-Authors

Avatar

Alexei Gonzalez-Estrada

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar

Claudia A. Kozinetz

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Dula

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar

Shimin Zheng

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Apurva Bansal

East Tennessee State University James H. Quillen College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge